Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
NCT06881446
·
clinicaltrials.gov ↗
COMPLETED
Status
2651
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma (HCC)
Sponsor
Zhongda Hospital